Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Wheeler

Showing results (151-160 of 453) with videos related to

Pageof 46
Sort By:
Journal of the American Society of Nephrology : JASN|November 15, 2023
Effect of Dialysate and Plasma Sodium on Mortality in a Global Historical Hemodialysis CohortJule Pinter, Brendan Smyth, Stefano Stuard, et al.
American Journal of Nephrology|October 6, 2024
The Impact of Primary Renal Diagnosis on Prognosis and the Varying Predictive Power of Albuminuria in the NURTuRE-CKD StudyThomas McDonnell, Philip A Kalra, Nicolas Vuilleumier, et al.
American Journal of Nephrology|December 9, 2019
Impact of Cardio-Renal-Metabolic Comorbidities on Cardiovascular Outcomes and Mortality in Type 2 Diabetes MellitusDavid Z I Cherney, Enrico Repetto, David C Wheeler, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 27, 2024
A note on performance metrics for the Kidney Failure Risk EquationOskar Ålund, Robert Unwin, Benjamin Challis, et al.
Preventive Oncology & Epidemiology|August 19, 2024
The Together for Health - Virginia Research Program: A Multi-Modal Approach for Population Health AssessmentBernard F Fuemmeler, Carrie A Miller, D Jeremy Barsell, et al.
Data in Brief|July 14, 2021
Data from a pooled post hoc analysis of 14 placebo-controlled, dapagliflozin treatment studies in patients with type 2 diabetes with and without anemia at baselineBergur V Stefánsson, Hiddo J L Heerspink, David C Wheeler, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 23, 2025
Effects of Dapagliflozin on Progression of CKD According to Different Rates of Pretrial eGFR LossHiddo J L Heerspink, Glenn M Chertow, Peter Rossing, et al.
International Journal of Cancer|September 27, 2014
Relationship between ambient ultraviolet radiation and non-Hodgkin lymphoma subtypes: a U.S. population-based study of racial and ethnic groupsElizabeth K Cahoon, Ruth M Pfeiffer, David C Wheeler, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 22, 2022
Estimated Lifetime Benefit of Combined RAAS and SGLT2 Inhibitor Therapy in Patients with Albuminuric CKD without DiabetesPriya Vart, Muthiah Vaduganathan, Niels Jongs, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 7, 2022
Effects of Dapagliflozin in People without Diabetes and with MicroalbuminuriaHiddo J L Heerspink, Glenn M Chertow, Niels Jongs, et al.
Pageof 46

Showing results (151-160 of 453) with videos related to

Sort By:
Pageof 46
Journal of the American Society of Nephrology : JASN|November 15, 2023
Effect of Dialysate and Plasma Sodium on Mortality in a Global Historical Hemodialysis CohortJule Pinter, Brendan Smyth, Stefano Stuard, et al.
American Journal of Nephrology|October 6, 2024
The Impact of Primary Renal Diagnosis on Prognosis and the Varying Predictive Power of Albuminuria in the NURTuRE-CKD StudyThomas McDonnell, Philip A Kalra, Nicolas Vuilleumier, et al.
American Journal of Nephrology|December 9, 2019
Impact of Cardio-Renal-Metabolic Comorbidities on Cardiovascular Outcomes and Mortality in Type 2 Diabetes MellitusDavid Z I Cherney, Enrico Repetto, David C Wheeler, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 27, 2024
A note on performance metrics for the Kidney Failure Risk EquationOskar Ålund, Robert Unwin, Benjamin Challis, et al.
Preventive Oncology & Epidemiology|August 19, 2024
The Together for Health - Virginia Research Program: A Multi-Modal Approach for Population Health AssessmentBernard F Fuemmeler, Carrie A Miller, D Jeremy Barsell, et al.
Data in Brief|July 14, 2021
Data from a pooled post hoc analysis of 14 placebo-controlled, dapagliflozin treatment studies in patients with type 2 diabetes with and without anemia at baselineBergur V Stefánsson, Hiddo J L Heerspink, David C Wheeler, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 23, 2025
Effects of Dapagliflozin on Progression of CKD According to Different Rates of Pretrial eGFR LossHiddo J L Heerspink, Glenn M Chertow, Peter Rossing, et al.
International Journal of Cancer|September 27, 2014
Relationship between ambient ultraviolet radiation and non-Hodgkin lymphoma subtypes: a U.S. population-based study of racial and ethnic groupsElizabeth K Cahoon, Ruth M Pfeiffer, David C Wheeler, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 22, 2022
Estimated Lifetime Benefit of Combined RAAS and SGLT2 Inhibitor Therapy in Patients with Albuminuric CKD without DiabetesPriya Vart, Muthiah Vaduganathan, Niels Jongs, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 7, 2022
Effects of Dapagliflozin in People without Diabetes and with MicroalbuminuriaHiddo J L Heerspink, Glenn M Chertow, Niels Jongs, et al.
Pageof 46